FIGURE 2
Tumor-specific survival of patients without intragenic PTEN/MMAC1 loss of heterozygosity (LOH; solid line) and of patients with intragenic PTEN/MMAC1 LOH (broken line).
FIGURE 2 | Modern Pathology
Tumor-specific survival of patients without intragenic PTEN/MMAC1 loss of heterozygosity (LOH; solid line) and of patients with intragenic PTEN/MMAC1 LOH (broken line).
